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A B S T R A C T   
The current chemical process for industrial indigo production puts a heavy burden on the environment. An 
attractive option would be to develop an alternative biotechnological process which does not rely on a petro-
chemical. This study describes a new biotransformation approach in which L-tryptophan is used as starting 
material. Its conversion to indigo can be achieved through recombinant overexpression of a bifunctional fusion 
enzyme, flavin-containing monooxygenase (FMO) fused to tryptophanase (TRP). First, TRP converts L-tryptophan 
into pyruvate, ammonia and indole. The formed indole serves as substrate for FMO, resulting in indigo forma-
tion, while pyruvate fuels the cells for regenerating the required NADPH. To optimize this bioconversion, 
different fusion constructs were tested. Fusing TRP to FMO at either the N-terminus (TRP-FMO) or the C-terminus 
(FMO-TRP) resulted in similar high expression levels of bifunctional fusion enzymes. Using whole cells and L- 
tryptophan as a precursor, high production levels of indigo could be obtained, significantly higher when 
compared with cells containing only overexpressed FMO. The TRP-FMO containing cells gave the highest yield of 
indigo resulting in full conversion of 2.0 g L-tryptophan into 1.7 g indigo per liter of culture. The process 
developed in this study provides an alternative biotransformation approach for the production of indigo starting 
from biobased starting material.   
1. Introduction 
The beginning of the 20th century saw the development of a 
petrochemical-based chemical process to synthesize indigo which 
rapidly replaced the traditional plant-based indigo production [1]. 
Despite the cost-effectiveness of the process, the hazardous and envi-
ronmentally unfriendly aspects of the chemical process provide a strong 
motivation to develop an environmentally benign indigo production 
process. Biotechnological production of indigo could develop into an 
attractive alternative approach. The first demonstration of the use of an 
recombinant microorganism for the fermentative production of indigo 
was already reported in 1983 [2]. A recombinant Escherichia coli strain 
carrying the Pseudomonas putida genes encoding naphthalene dioxyge-
nase (NDO) was used. This process depended on the native E. coli 
tryptophanase converting L-tryptophan to indole, which was then con-
verted to indoxyl by NDO, followed by spontaneous oxidation leading to 
indigo formation. Later, an improved engineered NDO-expressing 
strain, with an inactivated trpB gene encoding the β-subunit of L-tryp-
tophan synthase, was shown to produce indigo directly from glucose 
[3]. Nevertheless, indigo production was found to be limited by the first 
step of aromatic acids biosynthesis, the formation of 3-deoxy-D-ar-
abino-heptulosonate 7-phosphate (DAHP). DAHP synthase was found to 
be inactivated by indigo [4]. To overcome this limitation, a more 
thorough genetic engineering effort was made to boost the biosynthesis 
of L-tryptophan, and thus production of indigo [4]. Even though this 
example showed a great potential, further optimization is necessary to 
achieve a cost-efficient microbial indigo production. One limiting factor 
seems to be the rather complex multi-component NDO and formation of 
unwanted indigoid products. 
In the past decades, a large number of alternative natural and 
engineered enzymes have been identified capable of indigo synthesis 
through oxidation of indole [5–10]. Many indigo-forming enzymes use 
a flavin cofactor for the oxygenation reaction [1]. Several class B 
flavoprotein monooxygenases from bacterial origin, so-called fla-
vin-containing monooxygenases (FMOs), appear attractive biocatalysts 
as they are single component monooxygenases that merely require 
NADPH for activity [3,10]. Recently, it has been shown that, after 
optimization of conditions, indole conversion by FMO-expressing E. coli 
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cells can yield 0.92 g/L of indigo [11]. However, indole is a rather toxic, 
hazardous and petrol-based chemical. Therefore, we sought to inves-
tigate an alternative approach in which L-tryptophan is used as starting 
material which would allow the development of an indigo production 
process based on a renewable compound. This aromatic amino acid can 
be produced through hydrolysis of protein from biomass. Additionally, 
recent developments in metabolic engineering [12–14] have resulted in 
various efficient L-tryptophan producing bacterial strains. We explored 
the use of L-tryptophan as starting material for the design of an effective 
biotransformation process for indigo production with a bacterial FMO 
as key indigo-forming enzyme in combination with overexpression of 
tryptophanase fused to FMO. (Fig. 1) 
It is known that E. coli is capable of importing L-tryptophan from the 
medium [11]. Upon import, the native PLP-containing TRP will convert 
it into indole. In the absence of exogenous added L-tryptophan, E. coli 
has a very limited capacity in producing L-tryptophan and indole. Yet, it 
was recently shown that by adding L-tryptophan to the medium, rela-
tively high concentrations of indole (5 mM) can be attained [15]. This 
prompted us to use the combination of TRP and FMO to produce indigo 
using the non-toxic biobased amino acid L-tryptophan as the starting 
material. To boost the performance of this couple of enzymes, we 
decided to express both enzymes fused as a bifunctional fusion enzyme. 
The possibilities and advantages of enzyme fusions have been explored 
for various enzymes, including fusions of redox enzymes [16–18]. For 
example, we have previously fused phosphite dehydrogenase (PTDH) 
with FMOs, Baeyer-Villiger monooxygenases and a P450 mono-
oxygenase. This resulted in excellent expression levels of soluble and 
active self-sufficient monooxygenases [19,20]. In fact, Nature often 
brings enzymes in close proximity through subcellular reaction com-
partments, membrane-associated complexes on cellular surfaces, 
scaffold-organized proteins or protein clusters, and modular fusion 
enzymes [17]. There is compelling evidence showing that organized 
multienzyme complexes are relatively effective due to advantages such 
as superior stability, channeling of intermediates and/or simultaneous 
regulation [16,18]. 
For our study, we used the FMO from Methylophaga sp. strain SK and 
the TRP from Escherichia coli, strain K12. The dimeric soluble NADPH- 
dependent FAD-containing FMO was previously shown to be efficient 
in producing indigo from indole [3]. The PLP-dependent TRP catalyzes 
the hydrolytic β-elimination of L-tryptophan to indole, ammonia and 
pyruvate [21]. Both possible organizations of the fusion enzymes were 
constructed, either as TRP-FMO or FMO-TRP. The fused enzymes were 
expressed, purified and characterized. Using whole cells, expressing the 
fusion enzymes, conversions of L-tryptophan to indigo were performed 
and analyzed. Quantification of whole cell based indigo production 
revealed that TRP-FMO was the most effective construct, producing 
around 1.7 g of indigo per liter of culture using shake flasks. This work 
illustrates how fusion enzymes can be employed in whole cells for effi-
cient bioconversion. 
2. Materials and methods 
2.1. Chemicals, reagents, bacterial strains, and culture conditions 
Indigo and indole were purchased from Sigma Aldrich. NADP+ and 
NADPH were purchased from Oriental yeast Co (Tokyo, Japan). Other 
chemicals, medium components were purchased from either Sigma- 
Aldrich, Merck or Thermo Fisher. The protein markers (PageRuler™ 
Plus Prestained Protein Ladder, 10–250 kDa) were from Thermo Fisher. 
T4 ligase and the restriction enzyme BsaI were ordered from New En-
gland Biolabs. The PfuUltra Hotstart PCR master mix was purchased 
from Agilent Technologies. E. coli NEB 10-beta (New England Biolabs) 
chemically competent cells were used as a host for cloning the recom-
binant plasmids, and for protein expression. Precultures were grown in 
glass tubes with lysogeny broth (LB). For the subsequent main culture, 
LB supplemented with L-tryptophan was used in baffled flasks. 
2.2. Golden gate cloning for FMO-TRP and TRP-FMO 
The tryptophanase encoding gene was amplified from genomic DNA 
isolated from E. coli NEB10β using the following primers: forward, 
GAGGTCTCGCCATATGGAAAACTTTAAAC; reverse GTGGTCTCGCAA 
GTTAAACTTCTTTAAG). Using Golden Gate cloning, the gene was inserted 
into pBAD-His vector. The final construct was verified by sequencing. For 
expressing FMO of Methylophaga sp. strain SK1 (AF494423) we used an 
E. coli codon optimized gene synthesized by GeneScript. The FMO and TRP 
genes with different flanking regions which contain restriction sites were 
amplified by PCR. The fused constructs FMO-TRP and TRP-FMO were 
Fig. 1. Using FMO and TRP as biocatalysts, L-tryptophan is converted into indigo via indole and indoxyl as reaction intermediates.  
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cloned with the Golden Gate cloning technique. Primers used were 
designed to contain BsaI sites and linker regions (Table 1). The primers 
were designed such that the PCR products from FMO gene and the TRP 
gene could be inserted together into a pBAD vector. The pBAD vector 
contains two BsaI restriction sites, with an upstream region coding for an N- 
terminal 6xHis tag, an AraC promoter, and an ampicillin resistance gene. 
To transform host cells with the fusion constructs, the Golden Gate reaction 
mixture (50 μL) was added to chemically competent E. coli cells, and a heat 
shock (42 ◦C) was applied for 30 s. After overnight growth on an LB agar 
plate with ampicillin, colonies were picked and grown in LB, then the 
plasmids were isolated and sent for sequencing (GATC, Germany) to 
confirm the correct ligation of the genes. 
2.3. Site-directed mutagenesis 
The construct for expression of the TRP-FMO* mutant was prepared 
using the QuickChange kit (Stratagene, La Jolla, CA) (Table 2) [22]. The 
pBAD-His vector TRP-FMO was used as template DNA. The reactions 
were carried out in 25 μL of the supplied reaction mixture containing 10 
μM of each primer, and ~100 ng/μL of plasmid DNA, DMSO 5%, MgCl2 
50 mM, Pfu Ultra 12.5 μL and MQ water. The PCR cycle involved 
denaturation at 95 ◦C for 5 min, then 26 cycles of denaturation at 95 ◦C 
for 20 s, annealing 60 ◦C for 30 s, extension at 72 ◦C for 1 min/kb of 
plasmid length, and a final extension at 72 ◦C for 10 min. PCR products 
were purified using the PCR Clean-up kit and the template was digested 
with DpnI at 37 ◦C for 1 h to remove parental methylated DNA. To 
transform host cells with the fusion construct, the PCR reaction mixture 
(10 μL) was added to chemically competent E. coli cells, and a heat shock 
(42 ◦C) was applied for 30 s. After overnight growth on an LB agar plate 
with ampicillin, colonies were picked and grown in LB, then the plas-
mids were isolated and sent for sequencing (GATC, Germany) to confirm 
the correct ligation of the genes. 
2.4. Protein expression and conversions with whole cells 
E. coli cells NEB10β transformed with the pBAD FMO-TRP or pBAD 
TRP-FMO plasmid were grown overnight at 37 ◦C in 5 mL LB containing 
50 μg/mL ampicillin. The precultures were used to inoculate 50 mL of LB 
supplemented with 2.0 g L-tryptophan/L, containing 50 μg/mL ampicillin 
and 0.2 % L-arabinose, in 200 mL baffled flasks. The 50 mL cultures were 
incubated at the indicated temperatures and incubation times. Fusion 
enzymes were produced and purified as previously described [23]. 
2.5. SDS-PAGE and UV/Vis spectra 
During the purification, samples were taken for SDS-PAGE analysis. 
SDS loading dye was added to the samples and incubated at 95 ◦C for 
5 min, then centrifuged at 13,000 g for 1 min. The samples were loaded 
onto a precast SDS-PAGE gel (GenScript, USA), and the gels were run in a 
Mini-PROTEAN Tetra Vertical Electrophoresis Cell (Bio-Rad) at 120 V. 
The gel was stained with Coomassie InstantBlue (Expedeon, US). An 
UV/Vis absorption spectrum from 200 to 700 nm (V-330 Spectropho-
tometer, JASCO) was taken of each purified protein in a quartz cuvette 
(Hellma Analytics, Germany). The protein concentration for TRP-FMO 
(ε433 = 16.9 mM− 1 cm− 1) was calculated by using the absorbance 
values at 433 nm. 
2.6. Specific activity determination of PTDH-FMO/ FMO-TRP/ TRP- 
FMO 
For activity measurements and determination of kinetic measure-
ments, FMO activity was measured by following the NADPH depletion at 
340 nm (ε340,NADPH = 6.22 mM− 1 cm− 1). After the enzyme (0.5 μM) had 
been mixed with 4.0 mM indole in buffer (50 mM KPi buffer pH 7.5), 
NADPH (100 μM, final concentration) was added to start the reaction, 
briefly mixed in a cuvette, and then the reaction was followed (V-730 
Spectrophotometer, JASCO). For TRP activity, kinetic measurements 
were done by following the NADPH depletion at 340 nm by a coupled 
enzyme assay using alanine dehydrogenase. After the enzyme (0.5 μM) 
had been mixed with 10 mM L-tryptophan in buffer (50 mM KPi buffer 
pH 7.5), 100 μM NADH, 1 mM PLP, and 8 U/mL of alanine dehydro-
genase was added and briefly mixed in a cuvette, and then the reaction 
was followed (V-330 Spectrophotometer, JASCO). The slopes of the 
initial 40 s were used to calculate the activity rates (ε340,NADH = 6.22 
mM-1 cm-1). All measurements were made in duplicate or triplicate. 
2.7. Indigo quantification 
Indigo quantification was based on a method previously described 
[24]. First, a calibration curve was prepared using cultures with an 
empty pBAD plasmid and with added amounts of indigo. After the cul-
tures were harvested, indigo was extracted using ethyl acetate up to 
6 mg/L. Experiments were performed in triplicates. The 50 mL cultures 
containing indigo and cells were centrifuged at 4 ◦C 18,500 × g for 
20 min. Then, to liberate all the indigo from the cells, the pellet was 
resuspended in 10 mL of 50 mM KPi buffer pH 7.5, disrupted by soni-
cation, and the cell-free extract was obtained by centrifugation at 4 ◦C 
18,500 × g for 20 min. From this, the appropriate dilutions were made to 
dilute with 10 mL of water and extracted with 10 mL ethyl acetate. In-
digo content was determined spectrophotometrically at 600 nm. 
3. Results and discussion 
3.1. Enzyme fusions 
We have previously shown that FMO fused to His-tagged phosphite 
dehydrogenase (PTDH) could be overexpressed to high levels and that 
the fusion enzyme PTDH-FMO is capable to oxidize indole into indigo 
Table 1 
Primers used to obtain the fusion enzymes.  
Constructs  Primers used 
FMO-TRP FMO F CGGTCTCGCCATATGGCAACCCGTATCGCTATTC   
R CAATGGTCTCTGCAGAGCCCGATGCTTCTTTCGCCACCGGGATTTC  
TRP F CAATGGTCTCTGCAGAGCCCGATGCTTCTTTCGCCACCGGGATTTC   
R TGGTCTCTCAAGTTAAACTTCTTTAAGTTTTGCGGTGAAG 
TRP-FMO TRP F CGGTCTCGCCATATGGAAAACTTTAAACATCTC   
R CAATGGTCTCTGCAGAGCCCGAAACTTCTTTAAGTTTTGCGGTG  
FMO F TAGGTCTCGCTGCAGCTGGTATGGCAACCCGTATCGCTATTC   
R TGGTCTCTCAAGTTATGCTTCTTTCGCCAC  
Table 2 
Primers used to obtain site-directed mutants with the mutagenic region in 
capitals.  
Site directed mutants Primers used to amplify the TRP gene 
Double M15 L/S23A F cgtcaggcCTGgctcaactgcgtgcgtttcaaGCGgctcaggaaaaag  
R tttcctgagcCGCttgaaacgcacgcagttgagccaGgcctgacggac 
Single C78I FW F cgaaagaaATTctggaattcgcagattac  
R gaattccagAATttctttcgggccgtta  
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[25,26]. In this study, PTDH-FMO was produced again and used as a 
reference fusion enzyme to compare expression levels and the activity of 
the newly developed fusion enzymes. It is worth noting that the PTDH 
cannot be exploited in bioconversions because phosphite cannot enter 
E. coli cells. The two new pBAD-based expression constructs for pro-
ducing TRP-FMO and FMO-TRP were successfully constructed using the 
Golden Gate cloning method. The two fusion enzymes were equipped 
with an N-terminal His-tag to facilitate enzyme purification. A short 
flexible peptide linker (SGSAAG) was used to fuse the two enzymes, 
which was also successfully used for other fusion enzymes [27]. In our 
previous study, expression of PTDH-FMO resulted in about 60 mg of 
purified fusion enzyme per liter of culture [28]. By analogy, we antici-
pated that overexpression of TRP, an endogenous protein, and its fusion 
proteins in E. coli should be feasible. Expression experiments showed 
that the two new fusion proteins reached a similar high expression level 
of soluble protein as compared with PTDH-FMO (Fig. 2). 
SDS-PAGE analysis revealed a molecular weight of ~108 kDa for 
both newly created fusion enzymes, which is in agreement with the 
theoretical value 108.3 kDa. Both fusion enzymes could be purified by 
affinity chromatography, resulting in yellow protein fractions. An 
extinction coefficient of 167 mM− 1 cm− 1 at 280 nm for the total protein 
amount was used to determine the final yield of purified fusion enzyme; 
that ranged from 20 to 60 mg based on 1 L of culture broth. We inves-
tigated whether fusing these oligomeric enzymes (TRP being tetrameric 
and FMO being dimeric) affected their oligomerization state. For this, 
the newly designed purified fusion enzymes were analyzed using dy-
namic light scattering. This revealed that the fusion proteins mainly 
form oligomers of around 780 kDa (see Fig. 1 Supplementary data). This 
would correspond with an octamer, possibly composed of two tetra-
meric TRP modules, each decorated with four FMO dimers. 
In order to confirm that the activity of the individual fusion domains 
was preserved in the fusion enzymes, we first used two different chro-
mogenic tests. To probe FMO activity, the enzymes were incubated with 
indole and NADPH. A blue color appeared, which demonstrated the 
conversion of indole to indigo. The second test involved the use of 
Kovacs reagent which reacts with indole to form a pink-purple adduct 
[26]. Incubating the fusion enzymes with L-tryptophan and subsequent 
addition of Kovacs reagent resulted in formation of a clear pink color 
that confirmed that both fused enzymes were bifunctional. Fusing en-
zymes may influence the individual specific activities of the two do-
mains. Therefore, FMO and TRP activities were measured and compared 
to the activities of the purified PTDH-FMO and SUMO-TRP. Further-
more, to investigate the amount of FAD bound to FMO, the purified 
fusion domains were analyzed by UV–vis spectroscopy. The results 
revealed that for FMO-TRP, 80 % of the protein did not bind FAD while 
the other fusion enzymes where mainly purified as holo proteins 
(Table 3). This also explains the relatively low FMO activity of the pu-
rified FMO-TRP. The TRP activities of the two respective fusion enzymes 
were similar. The measured specific activities were in the same range as 
reported for the individual enzymes [29,30]. As the fused enzymes 
mainly retained their catalytic properties, we continued to study their 
use in the whole-cell conversion of indigo. One should also keep in mind 
that the enzyme activities may be underestimated as the conditions in 
the cell may boost enzyme activities. For example, the relatively high 
intracellular concentrations of the FAD and PLP cofactors will promote 
holo formation of both enzyme domains. Overall, these results indicated 
that FMO activity could be the limiting factor for the cascade reaction 
since the FMO activity of the bifunctional enzymes was relatively low 
when compared to TRP activity. 
3.2. Optimization of medium composition and temperature over time 
To identify optimal conditions for indigo production by cultures of 
TRP-FMO-expressing cells were grown at 24 ◦C for 40 h and at 30 ◦C for 
24 h using different media (TB, LB or M9 with supplements) with 3.0 g/L 
L-tryptophan. Indigo production performance was inspected visually. 
The optimal condition was found to be the use of LB while growing at 
24 ◦C for 40 h. Since the limiting step of the cascade reaction is likely the 
indole hydroxylation by FMO, we tested the effect of adding riboflavin 
50 μg/mL to medium in order to increase intracellular FAD production. 
Yet, this did not affect the production of indigo. The next step to opti-
mize indigo production was to find the ideal concentration of L-trypto-
phan. L-tryptophan concentrations were tested from 0.5 to 5.0 g/L and 
the formed indigo was determined. This revealed that a concentration of 
2.0 g/L resulted in the highest indigo concentration (Table 4). 
To assess the performance of the different fusion enzymes for indigo 
production, PTDH-FMO, FMO-TRP and TRP-FMO were independently 
expressed in E. coli cells. Indigo formation in the different cultures 
supplemented with 2.0 g/L of L-tryptophan was monitored over time 
(Fig. 3). Cells expressing TRP-FMO produced the most indigo reaching 
1.7 g/L after 3.5 days. When considering the molecular masses of indigo 
and tryptophan, this equals full conversion of the supplied L-tryptophan. 
Cells expressing FMO-TRP formed significantly less indigo (1.28 g/L) 
while PTDH-FMO produced even less (0.67 g/L). The lower yield with 
FMO-TRP is in line with the relative performance of this fusion enzyme 
upon purification (vide supra). From these results we can conclude that 
the TRP-FMO fusion enzyme was the best construct since it produced the 
highest levels of indigo. 
A previous study showed that the bacterial FMO could be improved 
for its performance on indole by introducing structure-inspired muta-
tions. Mutations were identified that increased the thermostability and 
that improved the kcat for indole [22]. Therefore, we decided to intro-
duce the respective mutations (M15 L/S23A/C78I) in the TRP-FMO 
fusion. This fusion variant was coined TRP-FMO* and tested for its 
performance in whole cell conversions of L-tryptophan. This revealed 
that the TRP-FMO* expressing cells reach a similar amount of indigo 
when compared with the fusion containing the wild type FMO (1.7 g/L), 
Fig. 2. SDS-PAGE analysis of cleared cell extracts for evaluating the expression 
of soluble FMO fusion enzymes. Lanes: M, markers; 1, control (empty pBAD); 2, 
PTDH-FMO; 3, FMO-TRP; 4, TRP-FMO. 
Table 3 
Specific activities of purified PTDH-FMO, FMO-TRP and TRP-FMO and esti-
mated amount of bound FAD cofactor. For TRP activity, 10 mM L-tryptophan 
was used, and for FMO activity, 4.0 mM indole was used.  
Enzyme TRP specific activity 
(U/mg) 






– 0.6 96 
FMO-TRP 1.7 0.2 20 
TRP-FMO 1.8 0.4 84  
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but in a much shorter time (40 h vs. 84 h, see Fig. 3). Clearly, the 
engineered FMO domain has a beneficial effect on the performance 
which confirms that the FMO activity is the limiting factor in converting 
L-tryptophan into indigo using the recombinant E. coli cells. 
4. Conclusion 
We demonstrated that L-tryptophan could serve as a non-hazardous 
starting material for indigo production by using TRP/FMO fusion en-
zymes. The fusion enzymes FMO-TRP and TRP-FMO were efficiently 
expressed as active bifunctional enzymes. E. coli cells expressing these 
fusion enzymes outperformed cells that only contained FMO activity. By 
optimizing reaction conditions, full conversion of 2.0 g/L of L-trypto-
phan could be obtained with cells containing TRP-FMO. The highest 
efficiency was obtained when using an engineered FMO variant as fusion 
partner. Except for L-tryptophan, no co-substrate was added to the me-
dium which indicates that the pyruvate that is liberated upon conversion 
of tryptophan is used for intracellular metabolism that fuels the NADPH- 
dependent FMO. This makes this biotransformation approach appealing 
as starting point for developing a biotechnological process for indigo 
production. A next step in developing such a process is the combined use 
of the herein developed L-tryptophan-converting E. coli with an engi-
neered microorganism that produces L-tryptophan. Alternatively, the 
developed indigo-producing E. coli could be equipped with a potent L- 
tryptophan synthesis system. By this, effective production of indigo may 
be achieved which merely requires renewable biomass resources. 
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